ALISPORIVIR (ALV) PLUS PEGINTERFERON/RIBAVIRIN (PR) ACHIEVES HIGH SVR12 RATES AMONG NULL RESPONDERS, IL28BCT/TT AND CIRRHOTIC HCVG1 PATIENTS (FUNDAMENTAL STUDY INTERIM ANALYSIS)

Resource

J. Hepatol., 58, S572-S572

Journal

J. Hepatol.

Journal Issue

58

Pages

-

Date Issued

2013

Date

2013

Author(s)

Buti, M.

Flisiak, R.

Rasenack, J.

Davis, G.

Alberti, A.

Goeser, T.

Stanciu, C.

Chuang, W. -L.

Tabak, F.

Kao, J. -H.

Streinu-Cercel, A.

Hofstetter, G.

Wang, J.

Avila, C.

Orsenigo, R.

URI

http://ntur.lib.ntu.edu.tw//handle/246246/259694

File(s)

Name

index.html

Size

23.1 KB

Format

HTML

Checksum

(MD5):fb6f3e830a639d743dfde53fca50f7e6